Cigna Investments Inc Nektar Therapeutics Transaction History

Cigna Investments Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$31.0 - $36.3 $224,316 - $262,666	-7,236 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$31.58 - $46.35 $228,512 - $335,388	7,236 New	7,236 $243,000
Q3 2018 Nov 13, 2018	SELL	$46.46 - $68.49 $236,388 - $348,477	-5,088 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$46.25 - $104.45 $28,860 - $65,176	-624 Reduced 10.92%	5,088 $249,000
Q1 2018 May 09, 2018	BUY	$57.4 - $108.44 $5,567 - $10,518	97 Added 1.73%	5,712 $607,000
Q4 2017 Jan 26, 2018	BUY	$23.02 - $60.5 $129,257 - $339,707	5,615	5,615 $335,000

145

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $146M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Cigna Investments Inc , based on Form 13F filings with the SEC.

Stay updated on Cigna Investments Inc with notifications on news.